Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Preparation and testing of a Haemophilus influenzae Type b/Hepatitis B surface antigen conjugate vaccine.

An SJ, Woo JS, Chae MH, Kothari S, Carbis R.

Vaccine. 2015 Mar 24;33(13):1614-9. doi: 10.1016/j.vaccine.2015.01.061. Epub 2015 Feb 7.

PMID:
25659268
2.

A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.

Kothari N, Kothari S, Choi YJ, Dey A, Briles DE, Rhee DK, Carbis R.

Vaccine. 2015 Feb 4;33(6):783-8. doi: 10.1016/j.vaccine.2014.12.032. Epub 2014 Dec 26.

PMID:
25545593
3.

Preparation and testing of a Vi conjugate vaccine using pneumococcal surface protein A (PspA) from Streptococcus pneumoniae as the carrier protein.

Kothari N, Genschmer KR, Kothari S, Kim JA, Briles DE, Rhee DK, Carbis R.

Vaccine. 2014 Sep 29;32(43):5755-60. doi: 10.1016/j.vaccine.2014.08.041. Epub 2014 Aug 27.

PMID:
25171842
4.

Purification of O-specific polysaccharide from lipopolysaccharide produced by Salmonella enterica serovar Paratyphi A.

Kothari S, Kim JA, Kothari N, Jones C, Choe WS, Carbis R.

Vaccine. 2014 May 1;32(21):2457-62. doi: 10.1016/j.vaccine.2014.02.090. Epub 2014 Mar 12.

PMID:
24631090
5.

Synthesis and immunogenicity evaluation of Salmonella enterica serovar Paratyphi A O-specific polysaccharide conjugated to diphtheria toxoid.

Ali A, An SJ, Cui C, Haque A, Carbis R.

Hum Vaccin Immunother. 2014;10(6):1494-8. doi: 10.4161/hv.28130. Epub 2014 Mar 6.

6.

5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.

Bhattacharya SK, Sur D, Ali M, Kanungo S, You YA, Manna B, Sah B, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Dhingra MS, Donner A, Nair GB, Lopez AL, Wierzba TF, Clemens JD.

Lancet Infect Dis. 2013 Dec;13(12):1050-6. doi: 10.1016/S1473-3099(13)70273-1. Epub 2013 Oct 18. Erratum in: Lancet Infect Dis. 2013 Dec;13(12):1011.

PMID:
24140390
7.

Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.

Sahastrabuddhe S, Carbis R, Wierzba TF, Ochiai RL.

Expert Rev Vaccines. 2013 Sep;12(9):1021-31. doi: 10.1586/14760584.2013.825450. Review.

PMID:
24053396
8.

A novel method for purification of Vi capsular polysaccharide produced by Salmonella enterica subspecies enterica serovar Typhi.

Kothari S, Kothari N, Kim JA, Lee E, Yoon YK, An SJ, Jones C, Choe WS, Carbis R.

Vaccine. 2013 Oct 1;31(42):4714-9. doi: 10.1016/j.vaccine.2013.08.037. Epub 2013 Aug 28.

PMID:
23994374
9.

Preparation and evaluation of immunogenic conjugates of Salmonella enterica serovar Typhi O-specific polysaccharides with diphtheria toxoid.

Ali A, An SJ, Cui C, Haque A, Carbis R.

Hum Vaccin Immunother. 2012 Feb;8(2):189-93. doi: 10.4161/hv.18350. Epub 2012 Feb 1.

PMID:
22426380
10.

Immune suppression induced by Vi capsular polysaccharide is overcome by Vi-DT conjugate vaccine.

An SJ, Yoon YK, Kothari S, Kim DR, Kim JA, Kothari N, Lee E, Park TH, Carbis R.

Vaccine. 2012 Feb 1;30(6):1023-8. doi: 10.1016/j.vaccine.2011.12.046. Epub 2011 Dec 20.

PMID:
22192846
11.

Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial.

Sur D, Kanungo S, Sah B, Manna B, Ali M, Paisley AM, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Han SH, Attridge S, Donner A, Ganguly NK, Bhattacharya SK, Nair GB, Clemens JD, Lopez AL.

PLoS Negl Trop Dis. 2011 Oct;5(10):e1289. doi: 10.1371/journal.pntd.0001289. Epub 2011 Oct 18.

12.

Physico-chemical properties of Salmonella typhi Vi polysaccharide-diphtheria toxoid conjugate vaccines affect immunogenicity.

An SJ, Yoon YK, Kothari S, Kothari N, Kim JA, Lee E, Kim DR, Park TH, Smith GW, Carbis R.

Vaccine. 2011 Oct 13;29(44):7618-23. doi: 10.1016/j.vaccine.2011.08.019. Epub 2011 Aug 16.

PMID:
21843575
13.

Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugates.

Cui C, Carbis R, An SJ, Jang H, Czerkinsky C, Szu SC, Clemens JD.

Clin Vaccine Immunol. 2010 Jan;17(1):73-9. doi: 10.1128/CVI.00266-09. Epub 2009 Nov 4.

14.

Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.

Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, Ali M, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Donner A, Ganguly NK, Nair GB, Bhattacharya SK, Clemens JD.

Lancet. 2009 Nov 14;374(9702):1694-702. doi: 10.1016/S0140-6736(09)61297-6. Epub 2009 Oct 8. Erratum in: Lancet. 2010 Oct 23;376(9750):1392.

PMID:
19819004
15.

Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.

Kanungo S, Paisley A, Lopez AL, Bhattacharya M, Manna B, Kim DR, Han SH, Attridge S, Carbis R, Rao R, Holmgren J, Clemens JD, Sur D.

Vaccine. 2009 Nov 16;27(49):6887-93. doi: 10.1016/j.vaccine.2009.09.008. Epub 2009 Sep 15.

PMID:
19761838
16.
17.

A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India.

Mahalanabis D, Lopez AL, Sur D, Deen J, Manna B, Kanungo S, von Seidlein L, Carbis R, Han SH, Shin SH, Attridge S, Rao R, Holmgren J, Clemens J, Bhattacharya SK.

PLoS One. 2008 Jun 4;3(6):e2323. doi: 10.1371/journal.pone.0002323.

18.

Optimization of Vi capsular polysaccharide production during growth of Salmonella enterica serotype Typhi Ty2 in a bioreactor.

Jang H, Yoon YK, Kim JA, Kim HS, An SJ, Seo JH, Cui C, Carbis R.

J Biotechnol. 2008 May 20;135(1):71-7. doi: 10.1016/j.jbiotec.2008.02.017. Epub 2008 Mar 2.

PMID:
18400326
19.

Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.

Shim DH, Chang SY, Park SM, Jang H, Carbis R, Czerkinsky C, Uematsu S, Akira S, Kweon MN.

Vaccine. 2007 Jun 15;25(25):4828-36. Epub 2007 Apr 20.

PMID:
17507120
20.

Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults.

Anh DD, Canh DG, Lopez AL, Thiem VD, Long PT, Son NH, Deen J, von Seidlein L, Carbis R, Han SH, Shin SH, Attridge S, Holmgren J, Clemens J.

Vaccine. 2007 Jan 22;25(6):1149-55. Epub 2006 Sep 29.

PMID:
17055622
21.

Vaccines against cholera, typhoid fever and shigellosis for developing countries.

Acosta CJ, Galindo CM, Deen J, Ochiai R, Lee HJ, von Seidlein L, Carbis R, Clemens JD.

Expert Opin Biol Ther. 2004 Dec;4(12):1939-51.

PMID:
15571456

Supplemental Content

Loading ...
Support Center